(Q81189083)

English

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease

scientific article published on 01 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Knop S

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Hebart H

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Gscheidle H

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Holler E

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kolb HJ

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Niederwieser D

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Einsele H

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

831-837

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16151429%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705132

0 references

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute graft-versus-host disease with monoclonal antibody OKT3. Clinical results and effect on circulating T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Muromonab CD3. A review of its pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection as a complication of OKT3 therapy in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705132

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81189083&oldid=2055616942"